BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21924544)

  • 1. Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study.
    Cha EK; Tirsar LA; Schwentner C; Christos PJ; Mian C; Hennenlotter J; Martini T; Stenzl A; Pycha A; Shariat SF; Schmitz-Dräger BJ
    Eur Urol; 2012 Jan; 61(1):185-92. PubMed ID: 21924544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.
    Cha EK; Tirsar LA; Schwentner C; Hennenlotter J; Christos PJ; Stenzl A; Mian C; Martini T; Pycha A; Shariat SF; Schmitz-Dräger BJ
    World J Urol; 2012 Dec; 30(6):847-52. PubMed ID: 23124847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of immunocytology in the evaluation of patients with painless gross hematuria].
    Schmitz-Dräger BJ; Tirsar LA; Schmitz-Dräger C; Dörsam J; Ebert T; Bismarck E
    Urologe A; 2010 Jun; 49(6):741-6. PubMed ID: 20373094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytology in the assessment of patients with asymptomatic hematuria.
    Schmitz-Dräger BJ; Tirsar LA; Schmitz-Dräger C; Dörsam J; Mellan Z; Bismarck E; Ebert T
    World J Urol; 2008 Feb; 26(1):31-7. PubMed ID: 18075743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
    Green DA; Rink M; Hansen J; Cha EK; Robinson B; Tian Z; Chun FK; Tagawa S; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF
    BJU Int; 2013 Mar; 111(3):404-11. PubMed ID: 22805163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytology in the assessment of patients with painless gross haematuria.
    Schmitz-Dräger B; Tirsar LA; Schmitz-Dräger C; Dörsam J; Bismarck E; Ebert T
    BJU Int; 2008 Feb; 101(4):455-8. PubMed ID: 18005211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
    Lucca I; Hofbauer SL; Leitner CV; de Martino M; Özsoy M; Susani M; Shariat SF; Klatte T
    Urology; 2016 Sep; 95():132-8. PubMed ID: 27316373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder Cancer.
    Huang S; Kou L; Furuya H; Yu C; Goodison S; Kattan MW; Garmire L; Rosser CJ
    Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1361-6. PubMed ID: 27383773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
    Nuhn P; May M; Sun M; Fritsche HM; Brookman-May S; Buchner A; Bolenz C; Moritz R; Herrmann E; Burger M; Tilki D; Trojan L; Perrotte P; Haferkamp A; Hohenfellner M; Wieland WF; Müller SC; Karakiewicz PI; Bastian PJ
    Eur Urol; 2012 Jan; 61(1):58-64. PubMed ID: 21840642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
    Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
    Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of patients with microscopic hematuria who are at greater risk for the presence of bladder tumors using a dedicated questionnaire and point of care urine test--a study by the members of Association of Urooncology, Turkey.
    Turkeri L; Mangir N; Gunlusoy B; Yildirim A; Baltaci S; Kaplan M; Bozlu M; Mungan A
    Asian Pac J Cancer Prev; 2014; 15(15):6283-6. PubMed ID: 25124612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective external validation of a bladder cancer detection model.
    Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
    J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Urine Based Genomic Assay to Triage Patients with Hematuria for Cystoscopy.
    van Kessel KEM; de Jong JJ; Ziel-van der Made ACJ; Roshani H; Haensel SM; Wolterbeek JH; Boevé ER; Oomens EHGM; van Casteren NJ; Krispin M; Boormans JL; Steyerberg EW; van Criekinge W; Zwarthoff EC
    J Urol; 2020 Jul; 204(1):50-57. PubMed ID: 31985322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine.
    Golijanin D; Sherman Y; Shapiro A; Pode D
    Urology; 1995 Aug; 46(2):173-7. PubMed ID: 7624989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer.
    Golijanin D; Shapiro A; Pode D
    J Urol; 2000 Dec; 164(6):1922-5. PubMed ID: 11061882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology.
    Odisho AY; Berry AB; Ahmad AE; Cooperberg MR; Carroll PR; Konety BR
    Eur Urol; 2013 May; 63(5):936-40. PubMed ID: 22521093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.
    Barbieri CE; Cha EK; Chromecki TF; Dunning A; Lotan Y; Svatek RS; Scherr DS; Karakiewicz PI; Sun M; Mazumdar M; Shariat SF
    BJU Int; 2012 Mar; 109(5):685-90. PubMed ID: 21851550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematuria screening test for urinary bladder mucosal infiltration in cervical cancer.
    Chuttiangtum A; Udomthavornsuk B; Chumworathayi B
    Asian Pac J Cancer Prev; 2012; 13(10):4931-3. PubMed ID: 23244084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytology in the assessment of patients with asymptomatic microhaematuria.
    Schmitz-Dräger BJ; Beiche B; Tirsar LA; Schmitz-Dräger C; Bismarck E; Ebert T
    Eur Urol; 2007 Jun; 51(6):1582-8; discussion 1588. PubMed ID: 17107748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.